Dr. Angela Cheung
Dr. Angela Cheung, Founding Director of UHN’s Osteoporosis Program and Senior Scientist at Toronto General Research Institute was recently awarded a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health. Tier 1 Research Chairs are the highest honour awarded in the Canadian medical research community.
“Dr. Cheung is really a superstar in her field, and she is very deserving of this national recognition,” said Dr. Nizar Mahomed, Director of UHN’s Arthritis Program. “This is a wonderful accomplishment for Dr. Cheung, and will be of tremendous benefit to our patients, who rely on our Osteoporosis Program’s world-leading care.”
Funding will provide Dr. Cheung with vital support to advance her research focused in the area of postmenopausal osteoporosis, especially in prevention and early diagnosis, and evaluation of new therapies and technologies. One in three Canadian women suffers from osteoporosis, and at least 80 per cent of fractures in individuals over the age of 50 are related to osteoporosis.
“To fight osteoporosis, we need to take a comprehensive approach and develop effective and sustainable programs for patient education, professional development, community outreach, and research, especially in the area of bone and muscle strength,” says Dr. Cheung. “I share this award with the exceptional people I work with in my clinical and research group, and look forward to what we can accomplish as a team to help people with this debilitating disease.”
In addition to her research activities, Dr. Cheung has been in clinical practice for more than 25 years. She obtained her M.D. degree from Johns Hopkins University School of Medicine in 1988 and her Ph.D. from Harvard University in 1997. She is currently a Fellow of the Royal College of Physicians of Canada.